Article info
PDFPancreatic cancer
Dominant negative inhibitors of signalling through the phosphoinositol 3-kinase pathway for gene therapy of pancreatic cancer
- Correspondence to:
Professor N R Lemoine
Cancer Research UK Clinical Centre, Barts and The London School of Medicine, Queen Mary’s University of London, Charterhouse Square, London EC1M 6BQ, UK; nick.lemoinecancer.org.uk
Citation
Dominant negative inhibitors of signalling through the phosphoinositol 3-kinase pathway for gene therapy of pancreatic cancer
Publication history
- Accepted June 8, 2004
- Revised June 1, 2004
- First published December 10, 2004.
Online issue publication
April 18, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2005 by Gut